ICU Medical, Inc. ICUI
164.95
(1.07)
(0.64%)
as of 25 Sep
- Market cap
- $4.2B
- P/E
- 137×
Follow ICUI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(0.35%) | 0.04% | 2.26% | 1.41% | |
| (0.18%) | 0.02% | 1.13% | 0.74% | ||
ROIC |
1.49% | 0.86% | 0.88% | 1.46% | |
Return on Tangible Assets |
(0.63%) | 0.06% | 4.06% | 2.60% | |
Average Days of Receivables |
30.13 | 29.53 | 34.03 | 31.02 | |
Free Cash Flow per Share |
2.52 | 3.69 | 3.31 | 6.12 | |
Free Cash Flow |
62.33 | 90.89 | 82.08 | 152.88 | |
Capital Expenditures |
(97.11) | (88.96) | (85.35) | (83.49) | |
Piotroski F-Score |
7.00 | 6.00 | 6.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
4.26% | 4.84% | 4.55% | 6.42% | |
Accounts Receivable Turnover |
12.70 | 12.28 | 11.60 | 11.90 | |
Accounts Payable Turnover |
8.66 | 9.32 | 7.55 | 8.27 | |
Inventory Turnover |
2.24 | 2.35 | 2.24 | 2.15 | |
Average Days of Payables |
42.53 | 39.98 | 47.44 | 41.42 | |
Days of Inventory on Hand |
154.13 | 159.51 | 165.12 | 168.67 | |
Tax Rate |
(1.30) | (0.56) | 3.26 | 41.05 | |
Research and Development Expense of Revenue |
3.83% | 3.92% | 3.96% | 4.00% | |
Selling, General and Administrative Expense of Revenue |
27.08% | 28.02% | 28.86% | 28.48% | |
Share Based Compensation of Revenue |
2.34% | 2.50% | 2.67% | 2.55% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(21.66) | 245.69 | 3.61 | 7.86 | |
Depreciation/Fixed assets |
0.46 | 0.46 | 0.46 | 0.46 | |
Capex/Depreciation |
(0.46) | (0.43) | (0.41) | (0.41) | |
Revenue per Share |
94.00 | 90.55 | 87.09 | 86.38 | |
Operating CF per Share |
6.46 | 7.30 | 6.76 | 9.45 | |
Capex per Share |
(3.93) | (3.61) | (3.45) | (3.34) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.04 | |
Net Profit Margin |
(0.32%) | 0.03% | 2.15% | 1.39% |
Columns are period end dates